Muscular Dystrophy Association and Coalition to Cure Calpain 3 Partner to Fund $300,000 Research Grant for Gene Therapy Development in Limb-Girdle Muscular Dystrophy
December 17, 2024 08:54 ET
|
Muscular Dystrophy Association
New York, Dec. 17, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) and Coalition to Cure Calpain 3 (C3) announced today collaborative funding of a $300,000 research grant to...
Muscular Dystrophy Association Announces Over $5 Million in Research Grants to Advance Neuromuscular Disease Research
December 16, 2024 08:42 ET
|
Muscular Dystrophy Association
New York, Dec. 16, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) announced today the awarding of 21 new grants with a total funding commitment of over $5 million toward...
NFL Players Nyheim Hines, Raheem Blackshear, Nick Scott, and Wear Custom Cleats to Support Muscular Dystrophy Association for the NFL My Cause My Cleats Campaign
November 27, 2024 09:00 ET
|
Muscular Dystrophy Association
New York, Nov. 27, 2024 (GLOBE NEWSWIRE) -- This December, hundreds of NFL players are donning custom-designed cleats as part of the 8th annual My Cause My Cleats campaign, spotlighting non-profit...
Agenda Announced for 2025 MDA Clinical & Scientific Conference Featuring Leading Speakers Dedicated to Groundbreaking Research and Clinical Achievements in Neuromuscular Disease
November 14, 2024 09:00 ET
|
Muscular Dystrophy Association
New York, Nov. 14, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association today announced the agenda including tracks and Chairs for the 2025 MDA Clinical & Scientific Conference being held...
Muscular Dystrophy Association Shines a Spotlight on National Family Caregivers Awareness Month in November
October 31, 2024 09:12 ET
|
Muscular Dystrophy Association
New York, Oct. 31, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) proudly highlights National Family Caregivers Awareness Month this November. MDA's month-long campaign emphasizes...
Muscular Dystrophy Association Launches Holiday Retail Campaign in Thousands of Retail Locations Nationwide
October 30, 2024 09:35 ET
|
Muscular Dystrophy Association
New York, Oct. 30, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today kicked off its largest annual Holiday Retail Campaign, spanning thousands of retail locations nationwide...
Muscular Dystrophy Association Advocate Rhys Hoskins Honored by his Peers with Two 2024 Players Choice Awards
October 28, 2024 08:32 ET
|
Muscular Dystrophy Association
New York, Oct. 28, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association and the Players Trust, the charitable arm of the Major League Baseball Players Association, are thrilled to announce...
MDA Kickstart Program Receives FDA Rare Pediatric Disease Designation and Orphan Drug Designation for Congenital Myasthenic Syndrome
October 24, 2024 12:50 ET
|
Muscular Dystrophy Association
New York, Oct. 24, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) proudly announces that its groundbreaking MDA Kickstart program has received both an FDA Rare Pediatric Disease...
NMD Pharma to Present Data on its Skeletal Muscle Targeted Therapy for Rare Neuromuscular Diseases at the 2024 AANEM Annual Meeting
October 11, 2024 07:00 ET
|
NMD Pharma
NMD Pharma to Present Data on its Skeletal Muscle Targeted Therapy for Rare Neuromuscular Diseases at the 2024 AANEM Annual Meeting Aarhus, Denmark, 11 October 2024 – NMD Pharma A/S, a...
NMD Pharma to Present Data on its Skeletal Muscle Targeted Therapy for Rare Neuromuscular Diseases at the 2024 AANEM Annual Meeting
October 11, 2024 01:00 ET
|
NMD Pharma
NMD Pharma to Present Data on its Skeletal Muscle Targeted Therapy for Rare Neuromuscular Diseases at the 2024 AANEM Annual Meeting Aarhus, Denmark, 11 October 2024 – NMD Pharma A/S, a...